PUBLIC RELEASE DATE: 7-Jan-2014 – Our research provides the first direct evidence that exposure to BPA during development, at the levels we see in our day-to-day lives, increases the risk for prostate cancer in human prostate tissue – “We believe… Read More ›
Food & Drug Administration
All Hackable from fetal monitors used in hospitals to pacemakers implanted in people
FDA, facing cybersecurity threats, tightens medical-device standards By Lena H. Sun and Brady Dennis, Published: June 12 | Updated: Thursday, June 13, 6:01 AM The Food and Drug Administration is tightening standards for a wide range of medical devices — from fetal… Read More ›
HHS Report Slams FDA’s Conflict of Interest Oversight: 42% were missing the required financial disclosures
2009 report posted for filing By Emily P. Walker, Washington Correspondent, MedPage Today WASHINGTON, Jan. 12 — The FDA fails to ensure that scientists conducting clinical trials on investigational products disclose financial conflicts of interest, found a review… Read More ›
Half of trials supporting FDA applications go unpublished
2008 study posted for filing Contact: Andrew Hyde press@plos.org 44-122-346-3330 Public Library of Science Over half of all supporting trials for FDA-approved drugs remained unpublished 5 years after approval, says new research published in this week’s PLoS Medicine. The most… Read More ›
Sifting Social Media for Early Signs of Adverse Drug Reactions
ScienceDaily (Sep. 21, 2012) — The National Science Foundation has awarded a $130,000 grant to a team co-led by University of Virginia professor Ahmed Abbasi to fund research that will analyze social media, including tweets and online discussion forums, to… Read More ›
Toxic drugs, toxic system: Sociologist predicts drug disasters “Drug disasters are literally built into the current system of drug testing and approvals in the United States,”
Repost 2008 Contact: Jackie Cooper jcooper@asanet.org 202-247-9871 American Sociological Association Study says harm from prescription drugs growing, cites fatal flaws in drug testing, approval and marketing BOSTON — Americans are likely to be exposed to unacceptable side effects of FDA-approved… Read More ›
Stanford researcher criticizes FDA plans to reduce oversight of off-label drug use: Pharmaceutial Free For All (No Rules)
Repost From April 2008 Contact: Rosanne Spector manishma@stanford.edu 650-725-5374 Stanford University Medical Center STANFORD, Calif. – Proposed guidelines from the U.S. Food and Drug Administration would allow companies to market more drugs for unapproved uses and are a step in… Read More ›
Experts challenge FDA over approval for new dose of Alzheimer’s drug – Aricept ( donepezil ) Ineffective and harmful
Observations: How the FDA forgot the evidence: The case of donepezil ( Aricept) 23 mg Approval for a new dose of a best-selling Alzheimer’s drug “breached the FDA’s own regulatory standard” and has led to “incomplete and distorted messages” about the… Read More ›
FDA Says No to Dying Patients Seeking Access to Experimental Drugs or Treatments
An important new bill addresses this situation. Action Alert! On July 25, famed civil rights attorney Jonathan Emord will be hosting a briefing on Capitol Hill about the FDA’s refusal to allow terminally ill patients access to experimental treatments. In… Read More ›
Engineering Evil 